Seed · Healthtech · Frankfurt, Germany
digid develops Cantisense, a revolutionary digital diagnostics platform that combines biomedical microelectromechanical systems (BioMEMS), nanotechnology, and AI for real-time health diagnostics. The company has achieved significant technological breakthroughs with their nanomechanical cantilever-based biosensor technology, successfully detecting SARS-CoV-2 viruses with high accuracy in just 5 minutes. Their proprietary platform enables portable, point-of-care testing that delivers electronic YES/NO results without requiring laboratory processing, positioning them to transform medical diagnostics across multiple biomarkers and disease detection applications.